(PresseBox) (Berlin, )In September Capsulution successfully concluded its laboratory expansion. This promises major benefits for the company in Berlin, as in the future the company will be able to develop pharmaceutical delivery systems based on nanotechnology for cytotoxic substances as well. Effective immediately, it is even possible to work with other highly effective new chemical entities (NCE's).
The newly created conditions for laboratory and labor safety contributes to a very high quality of development at work. A separate working area with a personnel and material lock as well as security workbenches guarantees a high security standard. "Our customers will profit from the expansion. The new laboratory technology will be used in the framework of the cooperation with AcriTec AG and Schering AG (abbr.), for instance.", explains Lutz Kröhne, pharmacist and project director at Capsulution. The focus of this collaboration is on developing special hydrogels, which not only possess properties suitable for transport and application, but also deliver nanoparticles in a controlled fashion. These nanoparticles are loaded with active substances, which are to be released by means of a configurable temporal path. The combination of functional hydrogels and stored nanoparticles thus permits a targeted substance release, simultaneously reducing the frequency of the application and increasing the safety of the therapy.